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1. INTRODUCTION {#jmd212044-sec-0001}
===============

Adult metabolic medicine (AMM) is a relatively new medical specialty, focusing on diagnosing, managing, and researching inherited metabolic diseases (IMD) in adults. It includes the care of both patients diagnosed with an IMD during childhood who survive into adulthood, and patients who are diagnosed in adulthood. These patients represent an expanding population. Thanks to better diagnosis and pediatric care over the last 30 years, patients are living longer. Improved metabolic and genetic diagnostic tools have also led to the detection of milder forms of many conditions, which present in adulthood. Moreover, through the expanding newborn screenings affected parents of the babies are increasingly detected. All these patients need long‐term follow up.[1](#jmd212044-bib-0001){ref-type="ref"}, [2](#jmd212044-bib-0002){ref-type="ref"} A recent survey of the metabolic European reference network showed that 50% of patients with IMD are adults (Scientific report, Board annual meeting 2018, MetabERN). Adult metabolic patients have their own peculiarity, compared to pediatric ones, showing an high phenotype variability depending not only from genotype, but also from modulation in response to environment modifications and to ontogenic changes and aging.[3](#jmd212044-bib-0003){ref-type="ref"}

In the past, metabolic medicine has been considered a pediatric discipline, and no formal postgraduate training or education in AMM exists in the majority of countries. As a result, current adult metabolic specialists (AMS) come from varied backgrounds. In 2010, as part of the Society for the Study of Inborn Error of Metabolism (SSIEM), a group of physicians with a special interest in AMM founded the Adult Metabolic Physicians Working Group (<http://www.ssiem.org/amp/welcome.asp>). The group meets every year at the annual SSIEM meeting for a specific session on IMD in adults, and a mailing list of members has been set up. The aim of this study was to describe the current landscape of education and training in AMM worldwide, and explore what steps are needed to further strengthen and establish the specialty of AMM.

2. METHODS {#jmd212044-sec-0002}
==========

A survey (see Supporting Information) consisting of 11 questions, divided into three sections---the participants qualifications and training in AMM, the availability and quality of education and training in AMM, and their opinion of the competencies required in an AMS---, was developed by the authors. AMS that are members of the SSIEM adult metabolic group (89 members) were contacted by email and asked to fill out the survey. Data were collected between July and December 2017.

Descriptive statistics were performed on categorical and numerical variables. Frequency distributions were used for categorical variables. For numerical variables, mean, median, interquartile range, SD, 25° and 75° percentile, minimum and maximum values were considered. Kolmogorov‐Smirnov test was performed for checking data distribution\'s normality on numerical variables. When variables were not normally distributed, nonparametric tests were performed and the median ± interquartile range were considered, for normally distributed variables mean ± SD were considered and parametric tests were performed. For question 1.2, the replies were first considered as dichotomous data (Yes or No); then, for the replies that have been answered as Yes, the replies were considered as categorical data (from 1‐not important to 4‐very important). For question 1.4, the percentage of adult patients (\>16 years) affected by IMD was compared to the total amount of patients followed by participants. Fisher\'s exact test was performed to search for differences in scores from question 2.1 based on replies to question 1.2, and on replies to question 1.3 considered as dichotomous data (ie, working experience in AMM ≤ or \>10 years). All statistical analyses were performed using SAS software, version 9.4 (SAS institute, Inc, Cary, North Carolina) and R 3.4.2. The significance level was set at .05.

3. RESULTS {#jmd212044-sec-0003}
==========

Forty‐two AMS (47.2%) from 18 different countries and 5 different continents (34 from Europe, 3 from North America, 2 from South America, 1 each from Africa, Asia, and Oceania) completed the questionnaire.

Participants were mostly specialists in internal medicine (38.1%), endocrinology (26.2%), genetics (21.4%), and neurology (21.4%). Fifteen out of 42 participants had more than one speciality. Four participants, working in the United Kingdom and Portugal, were officially recognized as metabolic specialists by their healthcare systems. No similar qualification was recognized in the other countries. Regarding working experience in AMM, 47.6% of participants were working in this field for more than 10 years, 35.7% for 5 to 10 years, 16.7% for less than 5 years. The average IMD patients load, as proportion of the total patient load of the participants was 54.4% ± 37.0%. Ninety‐five percent of AMS considered that day to day practical experience in their own unit had been important or very important for their professional development, while formal academic education or training programs had contributed importantly for only 27% of the respondents and not importantly or insignificantly for 58%. Congresses and conferences contributed importantly or very importantly for 81%. Other answers are reported in Figure [1](#jmd212044-fig-0001){ref-type="fig"}. Fourteen out of the 42 participants (33.3%) had been able to do an IMD internship in a foreign country, lasting from 1 month to 2 years.

![Participants\' education and training in adult metabolic medicine](JMD2-49-63-g001){#jmd212044-fig-0001}

The quality of available education and training in AMM was judged as generally poor or fair (73% of respondents). However, there were discrepancies among countries. Physicians from Portugal, France, Ireland, the United Kingdom, and the United States had a more positive opinion of the training available in their countries (data not shown). These training programs seem to have improved over time as younger AMS, with fewer years of experience in the field, tended to have more positive perceptions. In general, participants with more than 10 years of experience in AMM, compared to those with less than (or equal to) 10 years of experience had a less positive opinion of the available training (*P* = .038).

The available country‐specific training programs in AMM, as reported by participants, are summarized in Table [1](#jmd212044-tbl-0001){ref-type="table"}.

###### 

Available specific training programs in AMM, reported by participants

  Country          City                                                          Title                                                                                               Target population                                                                                              Level (National/regional/local)     Language     Duration                                                      Website
  ---------------- ------------------------------------------------------------- --------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------- ----------------------------------- ------------ ------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Australia        Sydney                                                        Full time metabolic fellowship across Children\'s Hospital WestMead and WestMead Hospital (adult)   Senior registrars in pediatric and adult metabolic medicine, or specialists (not specific for adult IEM)       Regional (NSW state‐wide service)   English      1 year, full time                                             Not applicable
  Canada           Vancouver                                                     National biochemical genetics training program                                                      Residents in genetics, pediatrics, internal medicine, and biochemistry                                         National                            English      1 month, full time adult exposure; total duration 24 months   [https://www.ccmg‐ccgm.org/training/training‐clinical.html](https://www.ccmg-ccgm.org/training/training-clinical.html)
  France           Paris                                                         Inter‐University Diploma in inherited metabolic diseases                                            Residents in pediatrics, genetics, neurology, internal medicine, endocrinology, hepatology, and biochemistry   National                            French       104 teaching hours, 6 weeks practical training                [http://www.scfc.parisdescartes.fr/index.php/descartes/formations/medecine/pediatrie‐medecine‐de‐l‐adolescent/diu‐maladies‐hereditaires‐du‐metabolisme/](http://www.scfc.parisdescartes.fr/index.php/descartes/formations/medecine/pediatrie-medecine-de-l-adolescent/diu-maladies-hereditaires-du-metabolisme/)(language)/fre‐FR
  Ireland          Dublin                                                        Special interest in metabolic diseases                                                              Residents in genetics or fellows                                                                               National                            English      2 years                                                       [https://www.mater.ie/services/adult‐metabolic‐service/](https://www.mater.ie/services/adult-metabolic-service/)
  Netherlands      Rotterdam/Amsterdam                                           Training in adult metabolic medicine for internal medicine residents                                Residents in internal medicine                                                                                 National                            Dutch        4 months full time                                            Not applicable
  Netherlands      Rotterdam/Amsterdam                                           Training in adult metabolic medicine for endocrinology fellows                                      Endocrinology fellows (senior residents)                                                                       Regional                            Dutch        6 months part time (1 day a week)                             Not applicable
  Portugal         Porto                                                         Ciclo de Estudos Especiais em Doenças Hereditárias do Metabolismo                                   Specialists pediatricians or internists                                                                        National                            Portuguese   2 years, full time                                            <https://dre.pt/>
  United Kingdom   London, Birmingham, Manchester, Cambridge, Cardiff, Glasgow   Metabolic medicine training program                                                                 Subspecialty for residents in chemical pathology and internal medicine                                         Regional                            English      5 years, full time                                            [www.jrcptb.org.uk](http://www.jrcptb.org.uk)

Abbreviation: AMM, Adult metabolic medicine.

When asked about possible ways to improve education and training in AMM, participants suggested: facilitating international internships in centers with experience in AMM (considered very important or important by 97%), implementing courses on IMD focusing on adults (85%) and establishing formal academic education in AMM (78%; Figure [2](#jmd212044-fig-0002){ref-type="fig"}).

![Suggested ways to improve education and training in adult metabolic medicine](JMD2-49-63-g002){#jmd212044-fig-0002}

The most important competencies for AMS were thought to be: recognition of signs and symptoms suggestive of an IEM (considered very important by 95%), knowledge of available treatments (95%), and ability to perform correct follow up (98%). Other answers are reported in Figure [3](#jmd212044-fig-0003){ref-type="fig"}.

![Competence of an adult metabolic specialist](JMD2-49-63-g003){#jmd212044-fig-0003}

4. DISCUSSION {#jmd212044-sec-0004}
=============

AMM is an expanding medical specialty. A previous survey by the SSIEM Adult Metabolic Physicians Working Group assessed the workload of the main international centers specializing in AMM and showed that the number of patients being referred to these services is increasing year on year. Adult metabolic patients in this study were affected by a wide spectrum of diseases, including in order of frequency amino acid, lysosomal, mithocondrial, peroxisomal, glycogen storage, fatty acid oxidation disorders, porphyrias and vitamin, and cofactor disorders. While many patients were being transitioned from pediatric metabolic services, more than 40% were only diagnosed in adulthood, demonstrating the need for adult physicians to be aware of these diseases.[2](#jmd212044-bib-0002){ref-type="ref"}

The physicians who participated in the current survey were also identified through the Adult Metabolic Physicians Working Group of the SSIEM, and are representative of leading centers that take care of adult patients. Among respondents, 83.3% had been working in AMM for more than 5 years. On average, these specialists were spending 54% of their time on adult patients with IEM. Despite this, only 4 out of the 42 responders were officially designated as specialists in AMM by their healthcare systems. Hence, in many countries, the role of AMS is not officially recognized, and no formal education or training in AMM exists. Unsurprisingly, as IMD in adulthood are often multisystem disorders,[4](#jmd212044-bib-0004){ref-type="ref"} the specialties which the respondents came from varied, although internal medicine and endocrinology were most frequent. Probably because of the lack of formal training, the vast majority of respondents considered that their training in AMM had mostly been based on practical experience rather than academic education. Seventy‐three percent of the participants felt the current state of available education and training in AMM was insufficient.

These data highlight the fact that currently it is difficult to obtain the basic knowledge and skills required to manage adult patients with IMD unless and until one is in post as an AMS. The corollary of this is that it is difficult to find young physicians who have sufficient knowledge and skills to appoint to a new AMS post. This situation is not sustainable and has been recognized by patients\' associations.[5](#jmd212044-bib-0005){ref-type="ref"} Bodies such as the European Commission have acknowledged the need to develop and implement effective training programs for rare disease specialists.[6](#jmd212044-bib-0006){ref-type="ref"}, [7](#jmd212044-bib-0007){ref-type="ref"} Because of the lack of suitably trained AMS, many adult patients who were diagnosed with IMD as children remain under the care of pediatricians. This is not viable in the long term: pediatric settings are not suitable for adult patients who in any case develop very different needs as they age (autonomy, pregnancy, comorbidities associated with aging).[4](#jmd212044-bib-0004){ref-type="ref"} It is critical that these patients can be transitioned to AMS. The timing of transition is not easy to define, especially for patients who may develop severe visceral or neuropsychiatric complications, which requires the identification of the right adult structures and professionals for care continuity.[8](#jmd212044-bib-0008){ref-type="ref"} Some countries, such as Portugal, UK, France, and the Netherlands[9](#jmd212044-bib-0009){ref-type="ref"} have already made important advances in this direction. The availability of educational opportunities dedicated to AMM is increasing, as testified by Table [1](#jmd212044-tbl-0001){ref-type="table"}. This means that the new generation of specialists will have more opportunities to train than the previous one. This education is also perceived to be of improved quality.

The results of the second and third part of this survey should help those trying to develop training programs in AMM. Trainees need the opportunity to gain hands on clinical experience, while the more obvious biochemical skills, such as interpreting diagnostic tests, were felt to be less important as they were well‐performed by specialist metabolic laboratories. The actions that were deemed important (facilitating international internships, providing courses on adult‐IMD, and creating a formal syllabus for education) will require funding and support from healthcare systems and professional societies. A further survey aimed at identifying which AMM centers can accept trainees from other countries would help in organizing international internships. A panel of experts in AMM could be set up to discuss an educational curriculum and how to organize and accredit training in AMM. Existing models, as used in the United Kingdom, where formal training including AMM already exists (either as a subspecialty of internal medicine or chemical pathology), could be adopted more widely. However, other options should also be considered, including the creation of a completely new medical specialty or as a credential for doctors trained in other specialities. Experience from other medical specialties, who have faced the problem of how to harmonize and implement training in developing disciplines, suggest that establishing an e‐learning platform can be effective (for example, infection control training for healthcare workers,[10](#jmd212044-bib-0010){ref-type="ref"}).

Finally, as adult metabolic diseases are often multisystem disorders and can show various complications, the AMP should work in a multidisciplinary team, involving other specialists such as nephrologist, cardiologist, gastroenterologist, and other healthcare professionals such as specialized nurses, dieticians, physical therapist, and psychologists. All these professionals should have adequate training in AMM, thus courses and congresses on AMM open to all these categories should be implemented.

5. CONCLUSIONS {#jmd212044-sec-0005}
==============

Worldwide, current available education and training in AMM is inadequate. There is a need for new, formal training programs to improve knowledge and competence in this rapidly expanding specialty.
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